Skip to content
Saturday 22 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,816.56
+0.64%
DAX
26,136.56
+0.59%
CAC 40
8,484.43
+0.37%
STOXX 50
6,462.22
+0.63%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 16 June 2021 3:38 pm  |  Updated:  Wednesday 16 June 2021 3:40 pm

‘Confident’ in vaccine supplies: Health department denies reports of Pfizer shortage

By: Amy O'Brien

Add as a preferred source on Google
Pfizer said that more than 1bn doses of the vaccine have been delivered globally, and it expects to deliver 2.1bn more doses by the end of the year, under contracts signed as of mid-July.

The Department of Health has denied reports of supply shortages of the Pfizer vaccine as the Covid jab rollout extends to over-21s, after the government delayed “Freedom Day” by four weeks to vaccinate more people.

“We are confident in our vaccine supplies as we rollout to younger age groups,” a spokesperson for the Department of Health and Social Care told City A.M.

They added that the vaccination programme is making “tremendous progress”, with 70 million doses delivered across the UK, including almost 8 million vaccines administered in London.

The health department’s vote of confidence comes after reports that supply shortages of the Pfizer vaccine have forced the NHS to slow down its Covid jab rollout, despite the government delaying “Freedom Day” by four weeks in order to accelerate the vaccination programme.

Just 1.2 million first doses were dispensed in the last week, compared with more than three million a week in March. The slowing vaccination rate means the UK now lags behind Germany, France and Italy.

Now that the jab rollout has been extended to over-21s in England, the NHS is more reliant on the Pfizer vaccine, after the government decided to restrict AstraZeneca to over-40s due to rare blood clot risks.

The vaccination rate varies considerably across the country, with the capital city in particular lagging behind. London has the lowest vaccine take-up of any region in the UK: around 68.6 per cent of Londoners have had their first vaccine, compared with the 79.2 per cent national average.

Health officials in London have requested 367,000 extra Pfizer and Moderna doses, to address the city’s low take-up of the vaccine.

London mayor Sadiq Khan tweeted on Tuesday: “I’m calling on the Government to allocate more Pfizer and Moderna vaccines to the capital so our younger age groups can get their first doses sooner rather than later.”

“Until more young Londoners are vaccinated, we won’t be able to beat this virus and fully reopen our city,” he added.

But the Department of Health and Social Care spokesperson said: “Vaccines are being distributed fairly across the UK and we recognise parts of the country have made more significant progress and gone slightly faster than others.”

“That is why we are extending opening hours and access to vaccine sites and putting more supply into areas that have more to do […] as we work to offer a first dose to all adults by 19 July.”

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Morning Wire Content

Related Topics

  • Coronavirus
  • Vaccine

Trending Articles

  • House prices in wealthy London boroughs fall by up to £300,000

  • As it happened: Miners fuel FTSE 100 recovery; oil jumps as Trump claims Strait of Hormuz

  • City law firm sues prominent Emirati business family

  • Amanda Blanc has worked her magic at Aviva

  • As it happened: FTSE 100 rallies after JD Sports drags on blue chips; oil jumps again

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Aviva profits jump following Direct Line acquisition

    Insurance
    Aviva's deal to buy Direct Line was agreed in March
  • Budget supermarket Iceland’s sneaky jab at Big Four management consultants

    Retail
    Iceland has reported its latest financial results.
  • Emergency government meeting held over high temperature amid ‘strain on public finances’

    Economics
    Aerial view of dry, brown farm fields affected by high temperatures, with a road and farm buildings.
  • IFF Reports Second Quarter 2026 Results; Announces Use of Proceeds Plan for Food Ingredients Divestiture

    Business Wire
  • ‘Absurd’: Government seeks quantum tech chief – no experience necessary

    Tech
    Advanced quantum computer with intricate circuits and glowing interface, illustrating cutting-edge technology innovations
  • Government to inject millions into electric vehicle firms despite mandate backlash

    Politics
    Car bodies on an assembly line in a UK car plant, showcasing EV manufacturing process
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook